https://www.sciencedaily.com/news/health_medicine/pharmaceuticals/ Research news on the pharmaceutical industry including new drugs and interventions. en-us Thu, 08 Oct 2026 10:10:37 EDT Thu, 08 Oct 2026 10:10:37 EDT 60 https://www.sciencedaily.com/images/scidaily-logo-rss.png https://www.sciencedaily.com/news/health_medicine/pharmaceuticals/ For more science news, visit ScienceDaily. https://www.sciencedaily.com/releases/2026/10/261007042059.htm Eating more sugar while taking antibiotics was linked to greater disruption of the gut microbiome and increased growth of potentially harmful bacteria. Researchers say temporarily cutting back on sweets during and after antibiotic treatment could be a simple way to reduce this damage, though clinical trials are still needed. Wed, 07 Oct 2026 09:06:21 EDT https://www.sciencedaily.com/releases/2026/10/261007042059.htm https://www.sciencedaily.com/releases/2026/10/261006234528.htm Researchers at Yale have identified a promising new approach to osteoarthritis that could do more than simply ease pain. The epilepsy drug lacosamide appears to block a protein involved in both pain signaling and cartilage destruction, helping damaged joints shift back toward repair in preclinical studies. Thu, 08 Oct 2026 09:52:56 EDT https://www.sciencedaily.com/releases/2026/10/261006234528.htm https://www.sciencedaily.com/releases/2026/10/261005012230.htm Scientists discovered that disrupting the chemical messages bacteria use to communicate can push dental plaque toward a healthier microbial balance. The approach could lead to new treatments for gum disease that control harmful bacteria without destroying beneficial species. Tue, 06 Oct 2026 23:55:00 EDT https://www.sciencedaily.com/releases/2026/10/261005012230.htm https://www.sciencedaily.com/releases/2026/10/261005011249.htm Scientists have found a surprising way to regrow damaged knee cartilage by blocking a protein that becomes more abundant with age. In old mice, the treatment restored naturally lost cartilage and also helped prevent osteoarthritis after ACL-like knee injuries, while human cartilage taken from knee replacement patients began producing new, functional joint cartilage after exposure to the same inhibitor. Tue, 06 Oct 2026 09:03:47 EDT https://www.sciencedaily.com/releases/2026/10/261005011249.htm https://www.sciencedaily.com/releases/2026/10/261001214127.htm Cancer immunotherapy can lose its punch when tumor-fighting T cells become exhausted, but researchers may have found a way to keep them going longer. Scientists at Memorial Sloan Kettering Cancer Center identified a signaling molecule called MEK that can push T cells to burn through their energy while producing cancer-killing proteins. In animal and laboratory studies, blocking MEK helped the cells conserve energy, survive longer, and remain active even in the harsh environment around tumors. Mon, 05 Oct 2026 05:24:29 EDT https://www.sciencedaily.com/releases/2026/10/261001214127.htm https://www.sciencedaily.com/releases/2026/09/260929053541.htm More than half of 16,000 apparently healthy adults had signs of atherosclerosis, with arterial plaques already detectable in about 1 in 13 people ages 18 to 29. Researchers say directly imaging the arteries could reveal hidden cardiovascular disease years or even decades before symptoms appear. Thu, 01 Oct 2026 07:46:21 EDT https://www.sciencedaily.com/releases/2026/09/260929053541.htm https://www.sciencedaily.com/releases/2026/09/260923035932.htm A 70-year-old leukemia drug is still revealing new secrets. Researchers found that removing a protein called NUDT5 protected cells from the drug, even though simply blocking the protein had little effect. The unexpected result points to a hidden cellular role that could help explain why people respond differently to certain leukemia treatments. Thu, 24 Sep 2026 08:47:28 EDT https://www.sciencedaily.com/releases/2026/09/260923035932.htm https://www.sciencedaily.com/releases/2026/09/260920222414.htm A large study suggests the cardiovascular benefits of GLP-1 drugs such as Ozempic, Wegovy, Mounjaro, and Zepbound can disappear surprisingly quickly when treatment stops. After two years off the medications, patients had a 22% higher risk of heart attack, stroke, and death compared with those who stayed on them. Mon, 21 Sep 2026 09:35:30 EDT https://www.sciencedaily.com/releases/2026/09/260920222414.htm https://www.sciencedaily.com/releases/2026/09/260920222354.htm Chronic inflammation tied to stress, lifestyle, mental health, and socioeconomic conditions may silently change the heart for years before any symptoms appear. People with the highest inflammation levels faced a 43% greater risk of heart attack and stroke, raising hopes that earlier testing and anti-inflammatory treatments could help prevent serious heart disease. Mon, 21 Sep 2026 07:35:13 EDT https://www.sciencedaily.com/releases/2026/09/260920222354.htm https://www.sciencedaily.com/releases/2026/09/260918024828.htm Scientists have identified the genetic cause behind the mysterious AnWj blood group antigen, solving a puzzle that began in 1972 and establishing a new blood group system called MAL. The discovery could make it much easier to find extremely rare AnWj-negative patients and donors and protect them from potentially dangerous transfusion reactions. Sat, 19 Sep 2026 06:14:15 EDT https://www.sciencedaily.com/releases/2026/09/260918024828.htm https://www.sciencedaily.com/releases/2026/09/260917003732.htm Newer blood thinners may do more than prevent strokes in people with Alzheimer’s disease and atrial fibrillation. Researchers found that patients taking NOACs experienced a slower decline in cognitive function than those using warfarin or no blood thinners. The effect was modest each year but could add up over time. Fri, 18 Sep 2026 05:48:31 EDT https://www.sciencedaily.com/releases/2026/09/260917003732.htm https://www.sciencedaily.com/releases/2026/09/260915232136.htm Scientists are testing a counterintuitive way to fight mesothelioma, an aggressive asbestos-linked cancer with few effective treatments. A new experimental mesothelioma drug kills cancer cells by disabling PRX3, an antioxidant defense that tumors use to survive intense oxidative stress. In an early clinical trial, it controlled disease progression in 67% of patients and produced encouraging survival results, raising hopes that the strategy could eventually be used against other cancers. Thu, 17 Sep 2026 01:11:51 EDT https://www.sciencedaily.com/releases/2026/09/260915232136.htm https://www.sciencedaily.com/releases/2026/09/260913081916.htm A wearable device has revealed nighttime hormone surges that may expose a frequently missed cause of high blood pressure. The discovery could help explain why primary aldosteronism often escapes standard blood tests and point toward a more accurate way to diagnose it. Mon, 14 Sep 2026 09:57:49 EDT https://www.sciencedaily.com/releases/2026/09/260913081916.htm https://www.sciencedaily.com/releases/2026/09/260912222856.htm AI analysis of 400,000 Reddit posts found that users of drugs such as Ozempic, Wegovy, Mounjaro, and Zepbound reported unexpected symptoms including menstrual changes, chills, hot flashes, and fatigue. Researchers cannot say the medications caused these problems, but the patterns may reveal overlooked signals worth studying. Sun, 13 Sep 2026 06:46:19 EDT https://www.sciencedaily.com/releases/2026/09/260912222856.htm https://www.sciencedaily.com/releases/2026/09/260911214306.htm Scientists have uncovered a natural braking system that helps the immune system switch off inflammation and prevent harmful immune cells from building up. Boosting this pathway in people reduced inflammation-related immune changes and sped up pain relief, pointing toward potential new treatments for chronic inflammatory diseases. Sat, 12 Sep 2026 21:44:05 EDT https://www.sciencedaily.com/releases/2026/09/260911214306.htm https://www.sciencedaily.com/releases/2026/09/260911214301.htm Scientists discovered that aging cells can use malfunctioning mitochondria to unlock inflammatory genes and keep the immune system stuck in a prolonged state of alert. Blocking one part of this process reduced inflammation and improved healthy aging in mice, suggesting a promising new strategy for fighting age-related decline. Sun, 13 Sep 2026 23:48:19 EDT https://www.sciencedaily.com/releases/2026/09/260911214301.htm https://www.sciencedaily.com/releases/2026/09/260911214241.htm GLP-1 drugs such as Ozempic, Wegovy, and Zepbound may increase hair-loss risk by 7% in men who are already genetically susceptible to male-pattern baldness. The findings suggest thinning hair may not be caused only by rapid weight loss and could also reflect a biological link between GLP-1 activity and hair follicles. Sat, 12 Sep 2026 22:18:14 EDT https://www.sciencedaily.com/releases/2026/09/260911214241.htm https://www.sciencedaily.com/releases/2026/09/260911003843.htm A major Ontario study found 24 common medication chains in which one drug’s side effects can be mistaken for a new medical problem, leading to another prescription. Researchers say closer medication reviews, pharmacist involvement, and automated alerts could help prevent these potentially harmful prescribing cascades. Fri, 11 Sep 2026 08:17:18 EDT https://www.sciencedaily.com/releases/2026/09/260911003843.htm https://www.sciencedaily.com/releases/2026/09/260909005207.htm People who drank at least one sugar-sweetened beverage a day had roughly 2.45 times the risk of gastric cancer compared with those who rarely consumed them, according to a decades-long study of more than 112,000 U.S. adults. Artificially sweetened drinks showed no similar association, though researchers stress that the findings do not prove sugary beverages cause cancer. Wed, 09 Sep 2026 22:56:17 EDT https://www.sciencedaily.com/releases/2026/09/260909005207.htm https://www.sciencedaily.com/releases/2026/09/260907201605.htm Researchers discovered that combinations of toxin-blocking proteins naturally found in rattlesnake blood can powerfully neutralize venom from several dangerous snake species. In lab tests, the mixtures were about 10 times more potent than a current commercial antivenom, pointing toward a new generation of nature-inspired snakebite treatments. Tue, 08 Sep 2026 09:54:56 EDT https://www.sciencedaily.com/releases/2026/09/260907201605.htm https://www.sciencedaily.com/releases/2026/09/260906170134.htm A large study of nearly 74,000 men suggests that long-term use of tadalafil, best known as Cialis, may be linked to a higher risk of glaucoma and other eye pressure problems. Men prescribed the drug for urinary symptoms caused by an enlarged prostate were 22% more likely to develop glaucoma, 32% more likely to develop ocular hypertension, and 33% more likely to be diagnosed with primary open-angle glaucoma or start glaucoma treatment over five years. Mon, 07 Sep 2026 03:03:04 EDT https://www.sciencedaily.com/releases/2026/09/260906170134.htm https://www.sciencedaily.com/releases/2026/09/260901070520.htm Starting statins soon after a type 2 diabetes diagnosis may do more than protect the heart. In a nationwide Danish study of more than 132,000 people, those who began statin treatment within a year of diagnosis had a 15% lower relative risk of developing dementia over 10 years compared with those who did not start statins. Tue, 08 Sep 2026 03:37:21 EDT https://www.sciencedaily.com/releases/2026/09/260901070520.htm https://www.sciencedaily.com/releases/2026/08/260829035228.htm People with chronic insomnia who used melatonin long term had a roughly 90% higher risk of developing heart failure over five years, according to a large preliminary study. The findings do not prove melatonin causes heart problems, but they raise new questions about the safety of taking the popular sleep supplement for extended periods. Sat, 29 Aug 2026 06:52:20 EDT https://www.sciencedaily.com/releases/2026/08/260829035228.htm https://www.sciencedaily.com/releases/2026/08/260829035216.htm Omega-3 and low-dose aspirin matched the effectiveness of antibiotics in a year-long study of patients with severe gum disease, with both approaches helping about 58% reach the treatment goal. The unexpected result could point to a new way to treat some patients while reducing reliance on antibiotics and the growing problem of antibiotic resistance. Sun, 30 Aug 2026 10:35:22 EDT https://www.sciencedaily.com/releases/2026/08/260829035216.htm https://www.sciencedaily.com/releases/2026/08/260828082330.htm CAR T-cell therapy dramatically reduced disease activity in six people with severe rheumatoid arthritis that had resisted other treatments, with three achieving medication-free remission. The treatment may work by clearing out harmful immune cells and effectively rebooting part of the immune system, although much larger studies are still needed. Sat, 29 Aug 2026 21:28:13 EDT https://www.sciencedaily.com/releases/2026/08/260828082330.htm https://www.sciencedaily.com/releases/2026/08/260824065605.htm Common medications may reshape the gut microbiome long after the last dose is taken. In a study of more than 2,500 people, researchers found lasting microbial changes linked not only to antibiotics, but also to antidepressants, beta-blockers, acid-reducing drugs, and benzodiazepines. Some effects were still detectable years later, suggesting past medication use may strongly influence the gut bacteria people carry today. Mon, 24 Aug 2026 09:14:50 EDT https://www.sciencedaily.com/releases/2026/08/260824065605.htm https://www.sciencedaily.com/releases/2026/08/260822015145.htm Gut bacteria can transform nitrate and plant-based iron from vegetables and other foods into protective molecules that may benefit the heart and metabolism. In experimental models, higher levels of these compounds were linked to lower blood pressure, better blood sugar control, healthier blood vessels, and less liver fat. Sun, 23 Aug 2026 22:48:52 EDT https://www.sciencedaily.com/releases/2026/08/260822015145.htm https://www.sciencedaily.com/releases/2026/08/260821012230.htm A simple yeast-based food supplement may help restore the immune system’s ability to fight cancer, according to new research in mice. Scientists found that yeast beta-glucan reprogrammed early immune cells in the bone marrow, leading to stronger, longer-lasting cancer-fighting responses against colorectal, skin, and breast cancer cells. Sat, 22 Aug 2026 06:34:22 EDT https://www.sciencedaily.com/releases/2026/08/260821012230.htm https://www.sciencedaily.com/releases/2026/08/260820202854.htm A hormone already known for curbing appetite and supporting weight loss may have a surprising second job: protecting the liver from inflammation and scarring. Researchers at McMaster University found that GDF15 activates a previously unknown brain-to-liver pathway that triggers the release of glucocorticoids, helping calm immune activity in the liver. Fri, 21 Aug 2026 07:38:41 EDT https://www.sciencedaily.com/releases/2026/08/260820202854.htm https://www.sciencedaily.com/releases/2026/08/260820002439.htm A compound made when gut bacteria break down dietary fiber may do more than briefly calm inflammation—it could leave a lasting protective “memory” in the gut. Northwestern Medicine researchers found that butyrate can reprogram intestinal lining cells so they continue encouraging anti-inflammatory immune responses even after the compound is gone. In mice, this effect boosted production of the immune-calming molecule IL-10 and reduced the severity of colitis-like disease. Thu, 20 Aug 2026 20:10:15 EDT https://www.sciencedaily.com/releases/2026/08/260820002439.htm https://www.sciencedaily.com/releases/2026/08/260816044830.htm Engineered probiotic bacteria were able to infiltrate pancreatic tumors, stimulate cancer-fighting immune cells, and slow tumor growth in animal studies. Even more strikingly, the treatment worked better when combined with chemotherapy, radiation, or immunotherapy. Wed, 19 Aug 2026 08:10:13 EDT https://www.sciencedaily.com/releases/2026/08/260816044830.htm https://www.sciencedaily.com/releases/2026/08/260814235842.htm Gut microbes need something to eat, and when fiber is limited, they may begin consuming proteins from the mucus lining that protects the gut. Researchers found that fiber can suppress this process, while indigestible plant proteins help microbes produce more beneficial compounds. Sat, 15 Aug 2026 10:30:28 EDT https://www.sciencedaily.com/releases/2026/08/260814235842.htm https://www.sciencedaily.com/releases/2026/08/260813045548.htm Orange juice may have a much bigger effect on the body than scientists once realized. Drinking it regularly appears to influence genes tied to inflammation, blood pressure, metabolism, and blood sugar control, while studies have also found improvements in cholesterol and blood vessel health. Researchers suspect natural citrus compounds such as hesperidin may be partly responsible. Even the gut microbiome may benefit. Thu, 13 Aug 2026 08:15:50 EDT https://www.sciencedaily.com/releases/2026/08/260813045548.htm https://www.sciencedaily.com/releases/2026/08/260808235003.htm A daily glass of 100% fruit juice or a smoothie may help improve more than just fruit intake. In a small four-week trial, participants who added one to a healthier diet showed significantly lower depression scores, hinting that a simple dietary change could also support mental well-being. Sun, 09 Aug 2026 22:09:47 EDT https://www.sciencedaily.com/releases/2026/08/260808235003.htm https://www.sciencedaily.com/releases/2026/08/260807235243.htm An intensive seven-day meditation retreat triggered striking changes across the brain and body, including shifts tied to neuroplasticity, immunity, metabolism, and natural pain relief. Participants also showed brain connectivity patterns resembling those associated with psychedelic experiences, suggesting that powerful altered states may be achievable without drugs. Sat, 08 Aug 2026 23:50:35 EDT https://www.sciencedaily.com/releases/2026/08/260807235243.htm https://www.sciencedaily.com/releases/2026/08/260806050702.htm A protein that evolved long before the human circulatory system may help unlock stronger cancer treatments. When C3 is produced inside tumors, it blocks immune-suppressing cells and gives immunotherapy a better chance to work. Researchers were even able to recreate this effect in resistant tumors, significantly improving survival in mice. Sat, 08 Aug 2026 09:31:21 EDT https://www.sciencedaily.com/releases/2026/08/260806050702.htm https://www.sciencedaily.com/releases/2026/07/260729010719.htm A liquid brushed onto cavities in seconds may spare many young children from pain, infection, and surgery. A major U.S. trial found that silver diamine fluoride stopped decay in more than half of treated baby teeth. The treatment requires no drilling, shots, or sedation, although it does permanently darken the decayed area. Wed, 29 Jul 2026 08:35:36 EDT https://www.sciencedaily.com/releases/2026/07/260729010719.htm https://www.sciencedaily.com/releases/2026/07/260726015250.htm Scientists used CRISPR to make prostate cancer cells easier for the immune system to detect and destroy. The experimental treatment dramatically improved the effects of immunotherapy in mice and may offer hope for other hard-to-treat tumors. Sun, 26 Jul 2026 08:36:23 EDT https://www.sciencedaily.com/releases/2026/07/260726015250.htm https://www.sciencedaily.com/releases/2026/07/260723084854.htm Ozempic, Wegovy, and similar drugs may deliver excellent health value, but covering them for millions of eligible patients could overwhelm insurance budgets. Researchers say better long-term support is needed and warn that low-cost compounded versions may carry serious safety risks. Fri, 24 Jul 2026 07:29:04 EDT https://www.sciencedaily.com/releases/2026/07/260723084854.htm https://www.sciencedaily.com/releases/2026/07/260722032121.htm A 25-year study found that frequent consumption of soda, sports drinks, and fruit juice beginning in childhood was linked to a higher risk of high blood pressure in adulthood. Swapping one daily drink for whole fruit, milk, or water could significantly reduce that risk. Thu, 23 Jul 2026 08:34:58 EDT https://www.sciencedaily.com/releases/2026/07/260722032121.htm https://www.sciencedaily.com/releases/2026/07/260722032108.htm Scientists have found a way to revive vancomycin, a powerful antibiotic that some dangerous bacteria have learned to resist. Instead of creating an entirely new drug, researchers paired vancomycin with a small molecule called pghi-4, which blocks a bacterial enzyme linked to resistance. The combination restored the antibiotic’s ability to kill drug-resistant E. faecium, raising hopes that similar chemical helpers could rescue other failing medicines. Wed, 22 Jul 2026 03:21:08 EDT https://www.sciencedaily.com/releases/2026/07/260722032108.htm https://www.sciencedaily.com/releases/2026/07/260719035927.htm Scientists may have uncovered one reason coffee is repeatedly associated with healthier aging and lower disease risk. Compounds in coffee appear to activate NR4A1, a receptor that helps protect cells from stress, inflammation, and damage. These protective effects disappeared when the receptor was removed, strengthening the connection. Surprisingly, plant-based compounds such as caffeic acid seemed far more active than caffeine itself. Sun, 19 Jul 2026 05:19:13 EDT https://www.sciencedaily.com/releases/2026/07/260719035927.htm https://www.sciencedaily.com/releases/2026/07/260716023552.htm A large laboratory study found that many commonly used sweeteners can directly change the growth of gut bacteria. Researchers identified more than 100 cases in which sweeteners behaved differently when combined with medications, caffeine, or flavorings. The combination of isosteviol and the antidepressant duloxetine was especially disruptive, reducing beneficial bacteria and overall microbial diversity. Fri, 17 Jul 2026 04:59:35 EDT https://www.sciencedaily.com/releases/2026/07/260716023552.htm https://www.sciencedaily.com/releases/2026/07/260714225532.htm Tiny plastic particles in drinking water may be doing more than contaminating the environment. New research suggests nanoplastics can actually help harmful bacteria survive by strengthening the slimy biofilms they form inside water systems. These tougher biofilms become more resistant to disinfectants, making them harder to remove and potentially increasing public health risks. Fri, 17 Jul 2026 09:14:10 EDT https://www.sciencedaily.com/releases/2026/07/260714225532.htm https://www.sciencedaily.com/releases/2026/07/260713084904.htm A new study found that chewing sugary gum after eating nitrate-rich vegetables or drinking beetroot juice helped the body produce more beneficial nitrite, leading to a temporary drop in blood pressure. Researchers hope the discovery will lead to healthier ways to enhance the cardiovascular and performance benefits of dietary nitrate without relying on sugar. Tue, 14 Jul 2026 20:24:05 EDT https://www.sciencedaily.com/releases/2026/07/260713084904.htm https://www.sciencedaily.com/releases/2026/07/260712011758.htm An unexpected study found that young non-smokers with healthier diets had higher rates of lung cancer, raising questions about whether pesticide exposure from conventionally grown produce could play a role. Researchers stress that the findings are preliminary and require further studies before any conclusions can be drawn. Mon, 13 Jul 2026 07:34:52 EDT https://www.sciencedaily.com/releases/2026/07/260712011758.htm https://www.sciencedaily.com/releases/2026/07/260709160655.htm A naturally occurring bacterium from amphibian intestines completely eliminated colorectal tumors in mice with a single treatment by both attacking cancer cells and activating the immune system. The findings point to a promising new type of cancer therapy that could one day work against many solid tumors. Fri, 10 Jul 2026 00:13:15 EDT https://www.sciencedaily.com/releases/2026/07/260709160655.htm https://www.sciencedaily.com/releases/2026/07/260709160648.htm Researchers found that the common blood pressure drug telmisartan can significantly improve the performance of the cancer drug olaparib, potentially expanding its benefits beyond patients with BRCA-related tumors. The combination is already being tested in human clinical trials after showing strong immune-boosting and anticancer effects in preclinical studies. Sat, 11 Jul 2026 19:42:15 EDT https://www.sciencedaily.com/releases/2026/07/260709160648.htm https://www.sciencedaily.com/releases/2026/07/260708022204.htm Poison control calls involving semaglutide (Ozempic and Wegovy) soared after the drug was approved for weight management, with researchers linking the increase to accidental dosing mistakes rather than intentional misuse. Simple education about proper weekly dosing and gradual dose increases could help prevent many of these avoidable incidents. Thu, 09 Jul 2026 00:02:10 EDT https://www.sciencedaily.com/releases/2026/07/260708022204.htm https://www.sciencedaily.com/releases/2026/07/260708022158.htm Tiny silica nanoparticles engineered to seek out prostate cancer caused tumor cells to self-destruct and supercharged the immune system in preclinical mouse studies. Combined with immunotherapy, the treatment produced complete remissions in multiple mice, raising hopes for a powerful new approach to prostate cancer. Wed, 08 Jul 2026 22:18:49 EDT https://www.sciencedaily.com/releases/2026/07/260708022158.htm https://www.sciencedaily.com/releases/2026/07/260707054114.htm A new study found that dietary fiber can determine whether beneficial intestinal worms help reduce inflammation or become essentially inactive. With plenty of fiber, the worms remained healthy and supported an anti-inflammatory response, while a low-fiber diet pushed them into a hibernation-like state that eliminated those benefits. Researchers also found that fiber-rich diets promoted healthier gut bacteria, whereas Western-style diets reduced microbial diversity and encouraged less desirable microbes. Fri, 10 Jul 2026 19:59:04 EDT https://www.sciencedaily.com/releases/2026/07/260707054114.htm https://www.sciencedaily.com/releases/2026/07/260707054111.htm A new once-daily weight-loss pill called orforglipron delivered better weight loss and blood sugar improvements for people with type 2 diabetes than the leading oral semaglutide in a major clinical trial. The tablet could offer a more convenient alternative to injectable drugs like Ozempic and Wegovy because it doesn't require refrigeration or special timing with meals. It's also cheaper to manufacture, which could expand access globally. Tue, 07 Jul 2026 05:41:11 EDT https://www.sciencedaily.com/releases/2026/07/260707054111.htm https://www.sciencedaily.com/releases/2026/07/260701205001.htm Researchers have cracked the code behind bacteria's ability to naturally manufacture multiple versions of powerful anti-cancer drugs. The discovery could make it much easier to engineer new cancer treatments inspired by nature, including improved versions of existing medicines. Wed, 08 Jul 2026 17:28:31 EDT https://www.sciencedaily.com/releases/2026/07/260701205001.htm https://www.sciencedaily.com/releases/2026/07/260701015237.htm Scientists have discovered that creatine may strengthen one of the immune system's most important cancer-fighting pathways by energizing dendritic cells that activate killer T cells. The promising results could eventually help make immunotherapy more effective, but they have not yet been tested in human patients. Wed, 08 Jul 2026 05:32:21 EDT https://www.sciencedaily.com/releases/2026/07/260701015237.htm https://www.sciencedaily.com/releases/2026/06/260626030430.htm A UCLA study has identified a hidden Achilles' heel in aggressive small cell cancers that have resisted new treatments for decades. Scientists found that tumors lacking the RB gene become critically dependent on the protein E2F3 for survival. Blocking E2F3 shut down tumor growth in laboratory models, and existing FDA-approved drugs may be able to exploit this vulnerability. The discovery could pave the way for faster development of more effective therapies. Sat, 04 Jul 2026 15:26:54 EDT https://www.sciencedaily.com/releases/2026/06/260626030430.htm https://www.sciencedaily.com/releases/2026/06/260623014014.htm Researchers found that a rare liver cancer evades immunotherapy by luring immune T cells away from the tumor and trapping them in nearby fibrous tissue. An FDA-approved drug called AMD3100 freed those T cells to attack the cancer, significantly improving the effectiveness of immunotherapy in tumor samples. Thu, 25 Jun 2026 10:38:45 EDT https://www.sciencedaily.com/releases/2026/06/260623014014.htm https://www.sciencedaily.com/releases/2026/06/260623014006.htm A massive national study found that nearly half of Americans with kidney failure who are referred for a transplant never even begin the evaluation process, and only 19% make it onto the transplant waitlist. Researchers discovered that factors such as where a person lives, whether they are married, their income level, language, age, and even which transplant center they use can dramatically affect their chances of moving forward. Wed, 01 Jul 2026 16:10:45 EDT https://www.sciencedaily.com/releases/2026/06/260623014006.htm https://www.sciencedaily.com/releases/2026/06/260620100434.htm Researchers found that highly drug-resistant bacteria from hospitals are also resistant to glyphosate, a commonly used weedkiller. The discovery suggests that agricultural herbicides may be helping antibiotic-resistant microbes survive and spread far beyond healthcare settings. Tue, 23 Jun 2026 07:31:51 EDT https://www.sciencedaily.com/releases/2026/06/260620100434.htm https://www.sciencedaily.com/releases/2026/06/260620100317.htm A new stem-cell-inspired technique allows scientists to grow vast numbers of immune-cell progenitors that can be engineered to hunt cancer and strengthen immune responses. In animal studies, the cells fought tumors, restored immune function, and showed promise as a durable, off-the-shelf therapy platform. Mon, 29 Jun 2026 16:58:56 EDT https://www.sciencedaily.com/releases/2026/06/260620100317.htm https://www.sciencedaily.com/releases/2026/06/260619101400.htm A new intranasal DNA vaccine may give the immune system an extra weapon against tuberculosis by targeting bacteria that can hide from antibiotics. In animal studies, it helped clear infections faster, reduced lung inflammation, and prevented relapse after treatment. The vaccine also enhanced the performance of drugs used against drug-resistant TB. Sat, 04 Jul 2026 04:54:49 EDT https://www.sciencedaily.com/releases/2026/06/260619101400.htm